Advertisement

Index by author

June 01, 2023; Volume 51,Issue 6

B

  1. Baillie, Thomas A.

    1. Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      William L. Fitch, Steven Smith, Michael Saporito, Gregory Busse, Mingbao Zhang, Julie Ren, Michael E. Fitzsimmons, Ping Yi, Stephen English, Adam Carter and Thomas A. Baillie
      Drug Metabolism and Disposition June 2023, 51 (6) 753-763; DOI: https://doi.org/10.1124/dmd.122.001218

  2. Bansal, Sumit

    1. A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and Children
      Sumit Bansal, Mayur K. Ladumor, Mary F. Paine and Jashvant D. Unadkat
      Drug Metabolism and Disposition June 2023, 51 (6) 743-752; DOI: https://doi.org/10.1124/dmd.122.001128

  3. Barnes, J. Paige

    1. Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine
      J. Paige Barnes, Shaoyun M. Yang, Taylor S. Thompson, Caithlyne M. Guevarra, Shaniya S. Pleasant, Tri Q. Do and Rachel D. Crouch
      Drug Metabolism and Disposition June 2023, 51 (6) 782-791; DOI: https://doi.org/10.1124/dmd.123.001257

  4. Busse, Gregory

    1. Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      William L. Fitch, Steven Smith, Michael Saporito, Gregory Busse, Mingbao Zhang, Julie Ren, Michael E. Fitzsimmons, Ping Yi, Stephen English, Adam Carter and Thomas A. Baillie
      Drug Metabolism and Disposition June 2023, 51 (6) 753-763; DOI: https://doi.org/10.1124/dmd.122.001218

C

  1. Carter, Adam

    1. Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      William L. Fitch, Steven Smith, Michael Saporito, Gregory Busse, Mingbao Zhang, Julie Ren, Michael E. Fitzsimmons, Ping Yi, Stephen English, Adam Carter and Thomas A. Baillie
      Drug Metabolism and Disposition June 2023, 51 (6) 753-763; DOI: https://doi.org/10.1124/dmd.122.001218

  2. Cerny, Matthew A.

    1. Human Absorption, Distribution, Metabolism, and Excretion Studies: Origins, Innovations, and Importance
      Matthew A. Cerny, Douglas K. Spracklin and R. Scott Obach
      Drug Metabolism and Disposition June 2023, 51 (6) 647-656; DOI: https://doi.org/10.1124/dmd.122.001006

  3. Chen, Huili

    1. Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Xiang Chen, Luyao Han, Yulin Zhao, Haoyan Huang, He Pan, Chenmeng Zhang, Huili Chen, Shanliang Sun, Sihui Yao, Xijing Chen and Yongjie Zhang
      Drug Metabolism and Disposition June 2023, 51 (6) 771-781; DOI: https://doi.org/10.1124/dmd.122.001245

  4. Chen, Xiang

    1. Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Xiang Chen, Luyao Han, Yulin Zhao, Haoyan Huang, He Pan, Chenmeng Zhang, Huili Chen, Shanliang Sun, Sihui Yao, Xijing Chen and Yongjie Zhang
      Drug Metabolism and Disposition June 2023, 51 (6) 771-781; DOI: https://doi.org/10.1124/dmd.122.001245

  5. Chen, Xijing

    1. Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Xiang Chen, Luyao Han, Yulin Zhao, Haoyan Huang, He Pan, Chenmeng Zhang, Huili Chen, Shanliang Sun, Sihui Yao, Xijing Chen and Yongjie Zhang
      Drug Metabolism and Disposition June 2023, 51 (6) 771-781; DOI: https://doi.org/10.1124/dmd.122.001245

  6. Cronin, Joseph M.

    1. Open Access
      Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research
      Joseph M. Cronin and Ai-Ming Yu
      Drug Metabolism and Disposition June 2023, 51 (6) 685-699; DOI: https://doi.org/10.1124/dmd.122.001008

  7. Crouch, Rachel D.

    1. Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine
      J. Paige Barnes, Shaoyun M. Yang, Taylor S. Thompson, Caithlyne M. Guevarra, Shaniya S. Pleasant, Tri Q. Do and Rachel D. Crouch
      Drug Metabolism and Disposition June 2023, 51 (6) 782-791; DOI: https://doi.org/10.1124/dmd.123.001257

D

  1. Ding, Xinxin

    1. Special Section on Perspectives on Drug Metabolism and Disposition, Part I—Editorial
      Yurong Lai and Xinxin Ding
      Drug Metabolism and Disposition June 2023, 51 (6) 645-646; DOI: https://doi.org/10.1124/dmd.123.001352

  2. Do, Tri Q.

    1. Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine
      J. Paige Barnes, Shaoyun M. Yang, Taylor S. Thompson, Caithlyne M. Guevarra, Shaniya S. Pleasant, Tri Q. Do and Rachel D. Crouch
      Drug Metabolism and Disposition June 2023, 51 (6) 782-791; DOI: https://doi.org/10.1124/dmd.123.001257

E

  1. Ebner, Thomas

    1. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans
      Shimon Nakashima, Rei Sato, Tatsuki Fukami, Takashi Kudo, Shiori Hashiba, Gaku Morinaga, Masataka Nakano, Eva Ludwig-Schwellinger, Akiko Matsui, Naoki Ishiguro, Thomas Ebner and Miki Nakajima
      Drug Metabolism and Disposition June 2023, 51 (6) 733-742; DOI: https://doi.org/10.1124/dmd.122.001113

  2. English, Stephen

    1. Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      William L. Fitch, Steven Smith, Michael Saporito, Gregory Busse, Mingbao Zhang, Julie Ren, Michael E. Fitzsimmons, Ping Yi, Stephen English, Adam Carter and Thomas A. Baillie
      Drug Metabolism and Disposition June 2023, 51 (6) 753-763; DOI: https://doi.org/10.1124/dmd.122.001218

  3. Esmaeeli, Mariam

    1. Open Access
      Inactivation of Human Aldehyde Oxidase by Small Sulfhydryl-Containing Reducing Agents
      Mariam Esmaeeli, Manfred Nimtz, Lothar Jänsch, Lloyd W. Ruddock and Silke Leimkühler
      Drug Metabolism and Disposition June 2023, 51 (6) 764-770; DOI: https://doi.org/10.1124/dmd.122.001244

F

  1. Fitch, William L.

    1. Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      William L. Fitch, Steven Smith, Michael Saporito, Gregory Busse, Mingbao Zhang, Julie Ren, Michael E. Fitzsimmons, Ping Yi, Stephen English, Adam Carter and Thomas A. Baillie
      Drug Metabolism and Disposition June 2023, 51 (6) 753-763; DOI: https://doi.org/10.1124/dmd.122.001218

  2. Fitzsimmons, Michael E.

    1. Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      William L. Fitch, Steven Smith, Michael Saporito, Gregory Busse, Mingbao Zhang, Julie Ren, Michael E. Fitzsimmons, Ping Yi, Stephen English, Adam Carter and Thomas A. Baillie
      Drug Metabolism and Disposition June 2023, 51 (6) 753-763; DOI: https://doi.org/10.1124/dmd.122.001218

  3. Fukami, Tatsuki

    1. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans
      Shimon Nakashima, Rei Sato, Tatsuki Fukami, Takashi Kudo, Shiori Hashiba, Gaku Morinaga, Masataka Nakano, Eva Ludwig-Schwellinger, Akiko Matsui, Naoki Ishiguro, Thomas Ebner and Miki Nakajima
      Drug Metabolism and Disposition June 2023, 51 (6) 733-742; DOI: https://doi.org/10.1124/dmd.122.001113

G

  1. Guevarra, Caithlyne M.

    1. Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine
      J. Paige Barnes, Shaoyun M. Yang, Taylor S. Thompson, Caithlyne M. Guevarra, Shaniya S. Pleasant, Tri Q. Do and Rachel D. Crouch
      Drug Metabolism and Disposition June 2023, 51 (6) 782-791; DOI: https://doi.org/10.1124/dmd.123.001257

H

  1. Han, Luyao

    1. Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Xiang Chen, Luyao Han, Yulin Zhao, Haoyan Huang, He Pan, Chenmeng Zhang, Huili Chen, Shanliang Sun, Sihui Yao, Xijing Chen and Yongjie Zhang
      Drug Metabolism and Disposition June 2023, 51 (6) 771-781; DOI: https://doi.org/10.1124/dmd.122.001245

  2. Hashiba, Shiori

    1. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans
      Shimon Nakashima, Rei Sato, Tatsuki Fukami, Takashi Kudo, Shiori Hashiba, Gaku Morinaga, Masataka Nakano, Eva Ludwig-Schwellinger, Akiko Matsui, Naoki Ishiguro, Thomas Ebner and Miki Nakajima
      Drug Metabolism and Disposition June 2023, 51 (6) 733-742; DOI: https://doi.org/10.1124/dmd.122.001113

  3. Huang, Haoyan

    1. Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Xiang Chen, Luyao Han, Yulin Zhao, Haoyan Huang, He Pan, Chenmeng Zhang, Huili Chen, Shanliang Sun, Sihui Yao, Xijing Chen and Yongjie Zhang
      Drug Metabolism and Disposition June 2023, 51 (6) 771-781; DOI: https://doi.org/10.1124/dmd.122.001245

I

  1. Ishiguro, Naoki

    1. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans
      Shimon Nakashima, Rei Sato, Tatsuki Fukami, Takashi Kudo, Shiori Hashiba, Gaku Morinaga, Masataka Nakano, Eva Ludwig-Schwellinger, Akiko Matsui, Naoki Ishiguro, Thomas Ebner and Miki Nakajima
      Drug Metabolism and Disposition June 2023, 51 (6) 733-742; DOI: https://doi.org/10.1124/dmd.122.001113

  2. Isoherranen, Nina

    1. Open Access
      Impact of Intracellular Lipid Binding Proteins on Endogenous and Xenobiotic Ligand Metabolism and Disposition
      King Clyde B. Yabut and Nina Isoherranen
      Drug Metabolism and Disposition June 2023, 51 (6) 700-717; DOI: https://doi.org/10.1124/dmd.122.001010

J

  1. Jänsch, Lothar

    1. Open Access
      Inactivation of Human Aldehyde Oxidase by Small Sulfhydryl-Containing Reducing Agents
      Mariam Esmaeeli, Manfred Nimtz, Lothar Jänsch, Lloyd W. Ruddock and Silke Leimkühler
      Drug Metabolism and Disposition June 2023, 51 (6) 764-770; DOI: https://doi.org/10.1124/dmd.122.001244

  2. Jin, Jing

    1. Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes
      Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes
      Jing Jin and Xiao-bo Zhong
      Drug Metabolism and Disposition June 2023, 51 (6) 672-684; DOI: https://doi.org/10.1124/dmd.122.001007

K

  1. Kudo, Takashi

    1. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans
      Shimon Nakashima, Rei Sato, Tatsuki Fukami, Takashi Kudo, Shiori Hashiba, Gaku Morinaga, Masataka Nakano, Eva Ludwig-Schwellinger, Akiko Matsui, Naoki Ishiguro, Thomas Ebner and Miki Nakajima
      Drug Metabolism and Disposition June 2023, 51 (6) 733-742; DOI: https://doi.org/10.1124/dmd.122.001113

L

  1. Ladumor, Mayur K.

    1. A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and Children
      Sumit Bansal, Mayur K. Ladumor, Mary F. Paine and Jashvant D. Unadkat
      Drug Metabolism and Disposition June 2023, 51 (6) 743-752; DOI: https://doi.org/10.1124/dmd.122.001128

  2. Lai, Yurong

    1. Special Section on Perspectives on Drug Metabolism and Disposition, Part I—Editorial
      Yurong Lai and Xinxin Ding
      Drug Metabolism and Disposition June 2023, 51 (6) 645-646; DOI: https://doi.org/10.1124/dmd.123.001352

  3. Leimkühler, Silke

    1. Open Access
      Inactivation of Human Aldehyde Oxidase by Small Sulfhydryl-Containing Reducing Agents
      Mariam Esmaeeli, Manfred Nimtz, Lothar Jänsch, Lloyd W. Ruddock and Silke Leimkühler
      Drug Metabolism and Disposition June 2023, 51 (6) 764-770; DOI: https://doi.org/10.1124/dmd.122.001244

  4. Li, Li

    1. Combined Oral Contraceptives As Victims of Drug Interactions
      Li Li, Xinning Yang, Doanh Tran, Shirley K. Seo and Yanhui Lu
      Drug Metabolism and Disposition June 2023, 51 (6) 718-732; DOI: https://doi.org/10.1124/dmd.122.000854

  5. Lu, Yanhui

    1. Combined Oral Contraceptives As Victims of Drug Interactions
      Li Li, Xinning Yang, Doanh Tran, Shirley K. Seo and Yanhui Lu
      Drug Metabolism and Disposition June 2023, 51 (6) 718-732; DOI: https://doi.org/10.1124/dmd.122.000854

  6. Ludwig-Schwellinger, Eva

    1. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans
      Shimon Nakashima, Rei Sato, Tatsuki Fukami, Takashi Kudo, Shiori Hashiba, Gaku Morinaga, Masataka Nakano, Eva Ludwig-Schwellinger, Akiko Matsui, Naoki Ishiguro, Thomas Ebner and Miki Nakajima
      Drug Metabolism and Disposition June 2023, 51 (6) 733-742; DOI: https://doi.org/10.1124/dmd.122.001113

M

  1. Matsui, Akiko

    1. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans
      Shimon Nakashima, Rei Sato, Tatsuki Fukami, Takashi Kudo, Shiori Hashiba, Gaku Morinaga, Masataka Nakano, Eva Ludwig-Schwellinger, Akiko Matsui, Naoki Ishiguro, Thomas Ebner and Miki Nakajima
      Drug Metabolism and Disposition June 2023, 51 (6) 733-742; DOI: https://doi.org/10.1124/dmd.122.001113

  2. Morinaga, Gaku

    1. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans
      Shimon Nakashima, Rei Sato, Tatsuki Fukami, Takashi Kudo, Shiori Hashiba, Gaku Morinaga, Masataka Nakano, Eva Ludwig-Schwellinger, Akiko Matsui, Naoki Ishiguro, Thomas Ebner and Miki Nakajima
      Drug Metabolism and Disposition June 2023, 51 (6) 733-742; DOI: https://doi.org/10.1124/dmd.122.001113

N

  1. Nakajima, Miki

    1. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans
      Shimon Nakashima, Rei Sato, Tatsuki Fukami, Takashi Kudo, Shiori Hashiba, Gaku Morinaga, Masataka Nakano, Eva Ludwig-Schwellinger, Akiko Matsui, Naoki Ishiguro, Thomas Ebner and Miki Nakajima
      Drug Metabolism and Disposition June 2023, 51 (6) 733-742; DOI: https://doi.org/10.1124/dmd.122.001113

  2. Nakano, Masataka

    1. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans
      Shimon Nakashima, Rei Sato, Tatsuki Fukami, Takashi Kudo, Shiori Hashiba, Gaku Morinaga, Masataka Nakano, Eva Ludwig-Schwellinger, Akiko Matsui, Naoki Ishiguro, Thomas Ebner and Miki Nakajima
      Drug Metabolism and Disposition June 2023, 51 (6) 733-742; DOI: https://doi.org/10.1124/dmd.122.001113

  3. Nakashima, Shimon

    1. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans
      Shimon Nakashima, Rei Sato, Tatsuki Fukami, Takashi Kudo, Shiori Hashiba, Gaku Morinaga, Masataka Nakano, Eva Ludwig-Schwellinger, Akiko Matsui, Naoki Ishiguro, Thomas Ebner and Miki Nakajima
      Drug Metabolism and Disposition June 2023, 51 (6) 733-742; DOI: https://doi.org/10.1124/dmd.122.001113

  4. Nimtz, Manfred

    1. Open Access
      Inactivation of Human Aldehyde Oxidase by Small Sulfhydryl-Containing Reducing Agents
      Mariam Esmaeeli, Manfred Nimtz, Lothar Jänsch, Lloyd W. Ruddock and Silke Leimkühler
      Drug Metabolism and Disposition June 2023, 51 (6) 764-770; DOI: https://doi.org/10.1124/dmd.122.001244

O

  1. Obach, R. Scott

    1. Human Absorption, Distribution, Metabolism, and Excretion Studies: Origins, Innovations, and Importance
      Matthew A. Cerny, Douglas K. Spracklin and R. Scott Obach
      Drug Metabolism and Disposition June 2023, 51 (6) 647-656; DOI: https://doi.org/10.1124/dmd.122.001006

P

  1. Paine, Mary F.

    1. A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and Children
      Sumit Bansal, Mayur K. Ladumor, Mary F. Paine and Jashvant D. Unadkat
      Drug Metabolism and Disposition June 2023, 51 (6) 743-752; DOI: https://doi.org/10.1124/dmd.122.001128

  2. Pan, He

    1. Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Xiang Chen, Luyao Han, Yulin Zhao, Haoyan Huang, He Pan, Chenmeng Zhang, Huili Chen, Shanliang Sun, Sihui Yao, Xijing Chen and Yongjie Zhang
      Drug Metabolism and Disposition June 2023, 51 (6) 771-781; DOI: https://doi.org/10.1124/dmd.122.001245

  3. Pleasant, Shaniya S.

    1. Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine
      J. Paige Barnes, Shaoyun M. Yang, Taylor S. Thompson, Caithlyne M. Guevarra, Shaniya S. Pleasant, Tri Q. Do and Rachel D. Crouch
      Drug Metabolism and Disposition June 2023, 51 (6) 782-791; DOI: https://doi.org/10.1124/dmd.123.001257

R

  1. Ren, Julie

    1. Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      William L. Fitch, Steven Smith, Michael Saporito, Gregory Busse, Mingbao Zhang, Julie Ren, Michael E. Fitzsimmons, Ping Yi, Stephen English, Adam Carter and Thomas A. Baillie
      Drug Metabolism and Disposition June 2023, 51 (6) 753-763; DOI: https://doi.org/10.1124/dmd.122.001218

  2. Riddick, David S.

    1. Fifty Years of Aryl Hydrocarbon Receptor Research as Reflected in the Pages of Drug Metabolism and Disposition
      David S. Riddick
      Drug Metabolism and Disposition June 2023, 51 (6) 657-671; DOI: https://doi.org/10.1124/dmd.122.001009

  3. Ruddock, Lloyd W.

    1. Open Access
      Inactivation of Human Aldehyde Oxidase by Small Sulfhydryl-Containing Reducing Agents
      Mariam Esmaeeli, Manfred Nimtz, Lothar Jänsch, Lloyd W. Ruddock and Silke Leimkühler
      Drug Metabolism and Disposition June 2023, 51 (6) 764-770; DOI: https://doi.org/10.1124/dmd.122.001244

S

  1. Saporito, Michael

    1. Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      William L. Fitch, Steven Smith, Michael Saporito, Gregory Busse, Mingbao Zhang, Julie Ren, Michael E. Fitzsimmons, Ping Yi, Stephen English, Adam Carter and Thomas A. Baillie
      Drug Metabolism and Disposition June 2023, 51 (6) 753-763; DOI: https://doi.org/10.1124/dmd.122.001218

  2. Sato, Rei

    1. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans
      Shimon Nakashima, Rei Sato, Tatsuki Fukami, Takashi Kudo, Shiori Hashiba, Gaku Morinaga, Masataka Nakano, Eva Ludwig-Schwellinger, Akiko Matsui, Naoki Ishiguro, Thomas Ebner and Miki Nakajima
      Drug Metabolism and Disposition June 2023, 51 (6) 733-742; DOI: https://doi.org/10.1124/dmd.122.001113

  3. Seo, Shirley K.

    1. Combined Oral Contraceptives As Victims of Drug Interactions
      Li Li, Xinning Yang, Doanh Tran, Shirley K. Seo and Yanhui Lu
      Drug Metabolism and Disposition June 2023, 51 (6) 718-732; DOI: https://doi.org/10.1124/dmd.122.000854

  4. Smith, Steven

    1. Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      William L. Fitch, Steven Smith, Michael Saporito, Gregory Busse, Mingbao Zhang, Julie Ren, Michael E. Fitzsimmons, Ping Yi, Stephen English, Adam Carter and Thomas A. Baillie
      Drug Metabolism and Disposition June 2023, 51 (6) 753-763; DOI: https://doi.org/10.1124/dmd.122.001218

  5. Spracklin, Douglas K.

    1. Human Absorption, Distribution, Metabolism, and Excretion Studies: Origins, Innovations, and Importance
      Matthew A. Cerny, Douglas K. Spracklin and R. Scott Obach
      Drug Metabolism and Disposition June 2023, 51 (6) 647-656; DOI: https://doi.org/10.1124/dmd.122.001006

  6. Sun, Shanliang

    1. Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Xiang Chen, Luyao Han, Yulin Zhao, Haoyan Huang, He Pan, Chenmeng Zhang, Huili Chen, Shanliang Sun, Sihui Yao, Xijing Chen and Yongjie Zhang
      Drug Metabolism and Disposition June 2023, 51 (6) 771-781; DOI: https://doi.org/10.1124/dmd.122.001245

T

  1. Thompson, Taylor S.

    1. Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine
      J. Paige Barnes, Shaoyun M. Yang, Taylor S. Thompson, Caithlyne M. Guevarra, Shaniya S. Pleasant, Tri Q. Do and Rachel D. Crouch
      Drug Metabolism and Disposition June 2023, 51 (6) 782-791; DOI: https://doi.org/10.1124/dmd.123.001257

  2. Tran, Doanh

    1. Combined Oral Contraceptives As Victims of Drug Interactions
      Li Li, Xinning Yang, Doanh Tran, Shirley K. Seo and Yanhui Lu
      Drug Metabolism and Disposition June 2023, 51 (6) 718-732; DOI: https://doi.org/10.1124/dmd.122.000854

U

  1. Unadkat, Jashvant D.

    1. A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and Children
      Sumit Bansal, Mayur K. Ladumor, Mary F. Paine and Jashvant D. Unadkat
      Drug Metabolism and Disposition June 2023, 51 (6) 743-752; DOI: https://doi.org/10.1124/dmd.122.001128

Y

  1. Yabut, King Clyde B.

    1. Open Access
      Impact of Intracellular Lipid Binding Proteins on Endogenous and Xenobiotic Ligand Metabolism and Disposition
      King Clyde B. Yabut and Nina Isoherranen
      Drug Metabolism and Disposition June 2023, 51 (6) 700-717; DOI: https://doi.org/10.1124/dmd.122.001010

  2. Yang, Shaoyun M.

    1. Mechanistic Investigation of the Time-Dependent Aldehyde Oxidase Inhibitor Hydralazine
      J. Paige Barnes, Shaoyun M. Yang, Taylor S. Thompson, Caithlyne M. Guevarra, Shaniya S. Pleasant, Tri Q. Do and Rachel D. Crouch
      Drug Metabolism and Disposition June 2023, 51 (6) 782-791; DOI: https://doi.org/10.1124/dmd.123.001257

  3. Yang, Xinning

    1. Combined Oral Contraceptives As Victims of Drug Interactions
      Li Li, Xinning Yang, Doanh Tran, Shirley K. Seo and Yanhui Lu
      Drug Metabolism and Disposition June 2023, 51 (6) 718-732; DOI: https://doi.org/10.1124/dmd.122.000854

  4. Yao, Sihui

    1. Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Xiang Chen, Luyao Han, Yulin Zhao, Haoyan Huang, He Pan, Chenmeng Zhang, Huili Chen, Shanliang Sun, Sihui Yao, Xijing Chen and Yongjie Zhang
      Drug Metabolism and Disposition June 2023, 51 (6) 771-781; DOI: https://doi.org/10.1124/dmd.122.001245

  5. Yi, Ping

    1. Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      William L. Fitch, Steven Smith, Michael Saporito, Gregory Busse, Mingbao Zhang, Julie Ren, Michael E. Fitzsimmons, Ping Yi, Stephen English, Adam Carter and Thomas A. Baillie
      Drug Metabolism and Disposition June 2023, 51 (6) 753-763; DOI: https://doi.org/10.1124/dmd.122.001218

  6. Yu, Ai-Ming

    1. Open Access
      Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research
      Joseph M. Cronin and Ai-Ming Yu
      Drug Metabolism and Disposition June 2023, 51 (6) 685-699; DOI: https://doi.org/10.1124/dmd.122.001008

Z

  1. Zhang, Chenmeng

    1. Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Xiang Chen, Luyao Han, Yulin Zhao, Haoyan Huang, He Pan, Chenmeng Zhang, Huili Chen, Shanliang Sun, Sihui Yao, Xijing Chen and Yongjie Zhang
      Drug Metabolism and Disposition June 2023, 51 (6) 771-781; DOI: https://doi.org/10.1124/dmd.122.001245

  2. Zhang, Mingbao

    1. Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment
      William L. Fitch, Steven Smith, Michael Saporito, Gregory Busse, Mingbao Zhang, Julie Ren, Michael E. Fitzsimmons, Ping Yi, Stephen English, Adam Carter and Thomas A. Baillie
      Drug Metabolism and Disposition June 2023, 51 (6) 753-763; DOI: https://doi.org/10.1124/dmd.122.001218

  3. Zhang, Yongjie

    1. Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Xiang Chen, Luyao Han, Yulin Zhao, Haoyan Huang, He Pan, Chenmeng Zhang, Huili Chen, Shanliang Sun, Sihui Yao, Xijing Chen and Yongjie Zhang
      Drug Metabolism and Disposition June 2023, 51 (6) 771-781; DOI: https://doi.org/10.1124/dmd.122.001245

  4. Zhao, Yulin

    1. Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9
      Xiang Chen, Luyao Han, Yulin Zhao, Haoyan Huang, He Pan, Chenmeng Zhang, Huili Chen, Shanliang Sun, Sihui Yao, Xijing Chen and Yongjie Zhang
      Drug Metabolism and Disposition June 2023, 51 (6) 771-781; DOI: https://doi.org/10.1124/dmd.122.001245

  5. Zhong, Xiao-bo

    1. Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes
      Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes
      Jing Jin and Xiao-bo Zhong
      Drug Metabolism and Disposition June 2023, 51 (6) 672-684; DOI: https://doi.org/10.1124/dmd.122.001007
Back to top

In this issue

Advertisement